Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis

[1]  M. Kudo,et al.  Association of Gankyrin and Stemness Factor Expression in Human Colorectal Cancer , 2013, Digestive Diseases and Sciences.

[2]  Hongyan Yuan,et al.  Ezrin gene expression and protein production in the CD44(+) subpopulation of SCC-9 cells in a malignant oral cancer cell line in vitro. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[3]  W. Liu,et al.  Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia , 2013, International journal of cancer.

[4]  D. Corbeil,et al.  CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges , 2013, The Journal of pathology.

[5]  Zhen-lin Liu,et al.  Malignant behaviorial characteristics of CD133+/− glioblastoma cells from a Northern Chinese population , 2012, Experimental and therapeutic medicine.

[6]  D. Ribeiro,et al.  Metastasis from oral cancer: an overview. , 2012, Cancer genomics & proteomics.

[7]  H. Nagatsuka,et al.  Analysis of immunoexpression of common cancer stem cell markers in ameloblastoma. , 2012, Experimental and therapeutic medicine.

[8]  M. Franco,et al.  Alkylation-induced genotoxicity as a predictor of DNA repair deficiency following experimental oral carcinogenesis , 2012, Journal of Molecular Histology.

[9]  Yi-Wei Chen,et al.  Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer‐derived CD133‐positive cells , 2011, Cancer.

[10]  D. Ribeiro,et al.  Oxidative DNA damage is a preliminary step during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide , 2011, Journal of Molecular Histology.

[11]  S. Chiou,et al.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. , 2010, Cancer research.

[12]  M. Wicha,et al.  Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.

[13]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[14]  Wenmei Li,et al.  The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development. , 2010, Oncology letters.

[15]  Y. Yen,et al.  A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. , 2010, Cancer letters.

[16]  M. Franco,et al.  The role of matrix metalloproteinases 2 and 9 during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide , 2010, Journal of Molecular Histology.

[17]  R. Carlos,et al.  Clinicopathological and immunohistochemical features of oral spindle cell carcinoma. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[18]  Feng Jiang,et al.  Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer , 2009, Molecular Cancer Research.

[19]  X. Peng,et al.  A clinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region. , 2008, International journal of oral and maxillofacial surgery.

[20]  K. Chan,et al.  Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.

[21]  Ian A. White,et al.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.

[22]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[23]  D. Salvadori,et al.  Survivin and inducible nitric oxide synthase production during 4NQO-induced rat tongue carcinogenesis: a possible relationship. , 2007, Experimental and molecular pathology.

[24]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[25]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[26]  R. Rozier,et al.  Continuity of care and early diagnosis of head and neck cancer. , 2006, Oral oncology.

[27]  D. Ribeiro,et al.  Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. , 2004, Oral oncology.

[28]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[29]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[30]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[32]  P. V. van Diest,et al.  Proliferation markers in tumours: interpretation and clinical value. , 1998, Journal of clinical pathology.

[33]  H Lumerman,et al.  Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. , 1995, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[34]  J. Celis,et al.  Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Z. Upton,et al.  Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[36]  A. Stepan,et al.  The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC). , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[37]  T. Kim.  CD133 Expression Is Not Restricted to Stem Cells, and Both CD133＋ and CD133− Metastatic Colon Cancer Cells Initiate Tumors. The Journal of Clinical Investigation 2008;118:2111-2120 , 2008 .

[38]  N. Dubrawsky.  Cancer statistics , 2022 .